These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1901925)

  • 1. Serum levels of glucose, insulin, and C-peptide during long-term D-ribose administration in man.
    Gross M; Zöllner N
    Klin Wochenschr; 1991 Jan; 69(1):31-6. PubMed ID: 1901925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral glucose decreases hepatic extraction of insulin.
    Gibby OM; Hales CN
    Br Med J (Clin Res Ed); 1983 Mar; 286(6369):921-3. PubMed ID: 6403135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Similar effects of pulsatile and constant intravenous insulin delivery.
    Kerner W; Brückel J; Zier H; Arias P; Thun C; Moncayo R; Pfeiffer EF
    Diabetes Res Clin Pract; 1988 Apr; 4(4):269-74. PubMed ID: 3286166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Incretin But Not Insulin Response after Oral versus Intravenous Branched Chain Amino Acids.
    Gojda J; Straková R; Plíhalová A; Tůma P; Potočková J; Polák J; Anděl M
    Ann Nutr Metab; 2017; 70(4):293-302. PubMed ID: 28595189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin and C-peptide levels after oral and intravenous glucose. Contribution of enteroinsular axis to insulin secretion.
    Hampton SM; Morgan LM; Tredger JA; Cramb R; Marks V
    Diabetes; 1986 May; 35(5):612-6. PubMed ID: 3514335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discrepancy between plasma C-peptide and insulin response to oral and intravenous glucose.
    Madsbad S; Kehlet H; Hilsted J; Tronier B
    Diabetes; 1983 May; 32(5):436-8. PubMed ID: 6341127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visfatin levels do not change after the oral glucose tolerance test and after a dexamethasone-induced increase in insulin resistance in humans.
    Marcinkowska M; Lewandowski KC; Lewiński A; Bieńkiewicz M; Basińska-Lewandowska M; Salata I; Randeva HS
    Endokrynol Pol; 2007; 58(3):188-94. PubMed ID: 17940983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of D-ribose administered continuously to healthy persons and to patients with myoadenylate deaminase deficiency.
    Gross M; Reiter S; Zöllner N
    Klin Wochenschr; 1989 Dec; 67(23):1205-13. PubMed ID: 2514319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circadian variations in plasma immunoreactive insulin (IRI) and C-peptide concentrations in adult onset (type II) diabetes mellitus.
    Nicolau GY; Haus E; Lakatua DJ; Bogdan C; Petrescu E; Sackett-Lundeen L; Stelea S; Stelea P
    Endocrinologie; 1984; 22(1):3-16. PubMed ID: 6369501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of insulin secretion by insulin and glucose in type II diabetes mellitus.
    Garvey WT; Revers RR; Kolterman OG; Rubenstein AH; Olefsky JM
    J Clin Endocrinol Metab; 1985 Mar; 60(3):559-68. PubMed ID: 3882736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of ranitidine infusion on glucose, insulin and C-peptide serum levels induced by oral glucose tolerance test in healthy subjects.
    Gentile S; Marmo R; Costume A; Orlando C; D'Alessandro R; De Bellis G; Porcellini M; Coltorti M
    Acta Diabetol Lat; 1986; 23(2):165-70. PubMed ID: 3529778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of postprandial glucose, insulin, C-peptide, and glucose-dependent insulinotropic peptide (GIP) in man by oral administration of a prostaglandin analogue (enprostil).
    Schwartz KE; Zaro B; Reynolds J; Duffy J; Saito T; Hunt JS; Sevelius H
    Horm Metab Res; 1988 Oct; 20(10):637-40. PubMed ID: 3146539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incretin hormone and insulin responses to oral versus intravenous lipid administration in humans.
    Lindgren O; Carr RD; Deacon CF; Holst JJ; Pacini G; Mari A; Ahrén B
    J Clin Endocrinol Metab; 2011 Aug; 96(8):2519-24. PubMed ID: 21593115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-dependent effects of oral and intravenous glucose on insulin secretion and clearance in normal humans.
    Tillil H; Shapiro ET; Miller MA; Karrison T; Frank BH; Galloway JA; Rubenstein AH; Polonsky KS
    Am J Physiol; 1988 Mar; 254(3 Pt 1):E349-57. PubMed ID: 3279811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiological role for cholecystokinin in reducing postprandial hyperglycemia in humans.
    Liddle RA; Rushakoff RJ; Morita ET; Beccaria L; Carter JD; Goldfine ID
    J Clin Invest; 1988 Jun; 81(6):1675-81. PubMed ID: 3290250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral and intravenous D-ribose and plasma insulin in healthy humans: effects of route of administration and of epinephrine and propranolol.
    Goodman C; Goetz FC
    Metabolism; 1970 Dec; 19(12):1094-103. PubMed ID: 5492047
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetics and pharmacodynamics of intranasal insulin administered to healthy subjects in escalating doses.
    Leary AC; Stote RM; Breedt HJ; O'Brien J; Buckley B
    Diabetes Technol Ther; 2005 Feb; 7(1):124-30. PubMed ID: 15738710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Miglitol (Bay m1099), a new alpha-glucosidase inhibitor, on glucose, insulin, C-peptide and GIP responses to an oral sucrose load in patients with post-prandial hypoglycaemic symptoms.
    Renard E; Parer-Richard C; Richard JL; Jureidini S; Orsetti A; Mirouze J
    Diabete Metab; 1991; 17(3):355-62. PubMed ID: 1884880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
    Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA
    Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential Effects of Oral and Intravenous Lipid Administration on Key Molecules Related to Energy Homeostasis.
    Vamvini MT; Hamnvik OP; Sahin-Efe A; Gavrieli A; Dincer F; Farr OM; Mantzoros CS
    J Clin Endocrinol Metab; 2016 May; 101(5):1989-97. PubMed ID: 26964729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.